SAMLYN CAPITAL, LLC - 31 Mar 2025 SCHEDULE 13G/A Report for Nektar Therapeutics Common Stock, $0.0001 par value (NKTR)

Filing Manager
SAMLYN CAPITAL, LLC
Reporting Manager
SAMLYN CAPITAL, LLC
Security
Nektar Therapeutics Common Stock, $0.0001 par value
Symbol
NKTR
Disclosed Ownership
0 shares
Ownership
0%
Form type
SCHEDULE 13G/A
Filing time
15 May 2025, 15:35:36 UTC
Date of event
31 Mar 2025
Previous filing
14 Feb 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
SAMLYN CAPITAL, LLC 0% 0 0 0 By: Samlyn, LP, its sole member, By: Samlyn GP, LLC, its general partner, By: /s/ Robert Pohly Robert Pohly, Managing Member*
SAMLYN, LP 0% 0 0 0 By: Samlyn GP, LLC, its general partner, By: /s/ Robert Pohly Robert Pohly, Managing Member*
ROBERT POHLY 0% 0 0 0 /s/ Robert Pohly Robert Pohly*